Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Toxicology Drug Screening Market Size Changed, over the years?

In the past few years, the size of the toxicology drug screening market has experienced significant growth. It is projected to increase from $19.56 billion in 2024 to $21.44 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.6%. Factors contributing to the growth during the historic period include a surge in drug abuse cases, the enforcement of workplace drug testing policies, the widespread use of toxicology screening in sports, the development of forensic toxicology services, and the escalating demand for toxicology reports in criminal investigations.

How Much Will the Toxicology Drug Screening Market Be Worth in 2029?

The market size of toxicology drug screening is set to experience substantial growth in the upcoming years, rising to $30.67 billion in 2029 with a compound annual growth rate (CAGR) of 9.4%. This expected growth during the forecasted period can be ascribed to the escalating demand for personalized medicine, augmented regulatory concentration on drug safety, increasing consumption of cannabis and synthetic drugs, expansion of health infrastructure in emerging markets, and growing cases of substance abuse. The forecasted period will also see major trends such as improvements in high-throughput screening technologies, enhanced use of AI in toxicology examination, growth of point-of-care toxicology tests, novel ideas in biomarker-based screening techniques, and progress in automation and robotics for drug screening.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24728&type=smp

Which is the Largest Company in the Toxicology Drug Screening Market?

Major companies operating in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, Alere Inc.

What Are the Main Market Drivers in the Toxicology Drug Screening Industry?

The toxicology drug screening market is projected to expand due to the escalating epidemic of drug misuse. Drug misuse, a destructive or excessive consumption of drugs for non-therapeutic reasons, negatively affects an individual’s health and overall life. The drug misuse trend escalates as individuals grapple with increasing stress and mental health issues, causing many to turn to substance misuse as a coping strategy. Toxicology drug screening plays a critical role in this context by identifying the presence of drugs or their by-products in an individual’s body, facilitating premature detection, diagnosis, and supervision of substance misuse or overdose. To illustrate, in August 2024, the National Records of Scotland (NRS), a government department in Scotland, reported 1,172 drug misuse deaths in 2023, a 12% increase (121 extra deaths) compared to 2022. As a result, the escalating drug misuse epidemic is propelling the growth of the toxicology drug screening market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24728&type=smp

How Is the Toxicology Drug Screening Market Segments Structured?

The toxicology drug screening market covered in this report is segmented –

1) By Type: Monitoring And Logging, Security, Storage And Continuous Integration Or Continuous Deployment, Management And Orchestration, Networking And Data Management Services, Other Types

2) By Test Type: Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity

3) By Technology Type: High-Throughput Screening, Genomics, Transcriptomics, Toxicogenomics, Molecular Screening

4) By Application: Immunotoxicity, Systemictoxicity, Developmental And Reproductive Toxicity (DART), Endocrine Disruption, Other Applications

5) By End Users: Hospitals, Clinics, Contract Research Organizations (CROs), Pharmaceutical Companies, Workplace Testing Facilities

Subsegments:

1) By Monitoring And Logging: Real-Time Drug Monitoring Systems, Bioanalytical Instrumentation Logs, Toxicity Alert Notification Systems, Compliance And Audit Trail Monitoring

2) By Security: Data Encryption Solutions For Lab Reports, Access Control Systems For Toxicology Data, Secure Sample Tracking Systems, HIPAA Or GDPR-Compliant Drug Testing Platforms

3) By Storage And Continuous Integration Or Continuous Deployment: Cloud-Based Sample Data Storage Solutions, Automated Toxicology Report Generation Pipelines, LIMS (Laboratory Information Management Systems) Integration Tools, Version Control For Test Protocols And Databases

4) By Management And Orchestration: Workflow Automation Tools For Toxicology Labs, Centralized Dashboard For Drug Screening Management, Multi-Site Test Scheduling And Coordination Platforms, Vendor Management Systems For Lab Supplies

5) By Networking And Data Management Services: Interoperability Platforms For Healthcare Data Exchange, Toxicology Data Integration Services With EHR/EMR Systems, Remote Access For Toxicology Results And Analysis, Data Warehousing For Toxicology And Screening Records

6) By Other Types: AI-Powered Predictive Toxicology Platforms, Mobile Drug Screening Applications, Blockchain-Based Chain Of Custody Solutions, Voice And Image Recognition Tools In Toxicology

What Strategic Trends Are Transforming the Toxicology Drug Screening Market?

Leading corporations in the toxicology drug screening market are increasingly directing their efforts towards the introduction of cutting-edge solutions such as forensic toxicology screening. This innovation aims to improve the speed and precision of substance detection in clinical, forensic, and occupational environments. Forensic toxicology screening entails the examination of biological specimens to detect and identify drugs, toxins, or poisons involved in criminal activities, accidents, or fatalities, primarily for legal investigative reasons. For example, Thermo Fisher Scientific Inc., a biotechnology and life sciences firm based in the US, unveiled the ToxSpec Analyzer in June 2022. This comprehensive LC-MS (liquid chromatography-mass spectrometry) solution is specifically designed for clinical and forensic toxicology screening applications. The system unifies hardware, software, and validated methodologies to automate and simplify the drug analytes screening process, making it user-friendly even for labs unfamiliar with LC-MS/MS technology. Through this innovation, the ToxSpec Analyzer enhances workflow productivity, heightens identification certainty, and provides the option to incorporate new compounds as necessary.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/toxicology-drug-screening-global-market-report

Which Global Regions Offer the Highest Growth in the Toxicology Drug Screening Market?

North America was the largest region in the toxicology drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the toxicology drug screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24728

This Report Delivers Insight On:

1. How big is the toxicology drug screening market, and how is it changing globally?

2. Who are the major companies in the toxicology drug screening market, and how are they performing?

3. What are the key opportunities and risks in the toxicology drug screening market right now?

4. Which products or customer segments are growing the most in the toxicology drug screening market?

5. What factors are helping or slowing down the growth of the toxicology drug screening market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model